human recombinant erythropoietin alfa (PEGylated) (The Center of Molecular Immunology/Center for Genetic Engineering and Biotechnology)

N/A

报告时间: 2025/02/01 20:00:06

基本信息

药物名称human recombinant erythropoietin alfa (PEGylated) (The Center of Molecular Immunology/Center for Genetic Engineering and Biotechnology)

药物别称hu-r-EPO (PEGylated) (The Center of Molecular Immunology/Center for Genetic Engineering and Biotechnology)

药物类型生物药 > 蛋白类药物 > 重组蛋白

作用机制促红细胞生成素受体激动剂

靶点促红细胞生成素受体

治疗领域 / 适应症贫血

全球批准适应症N/A

中国批准适应症N/A

首批国家/区域N/A

首批日期N/A

国家/区域古巴

是否复方否

全球最高研发状态无进展 (临床前)

中国最高研发状态N/A

注册分类N/A

活跃公司N/A

活跃适应症N/A

非活跃适应症贫血

ATC代码N/A